vs
Side-by-side financial comparison of HAEMONETICS CORP (HAE) and National Storage Affiliates Trust (NSA). Click either name above to swap in a different company.
HAEMONETICS CORP is the larger business by last-quarter revenue ($339.0M vs $187.0M, roughly 1.8× National Storage Affiliates Trust). HAEMONETICS CORP runs the higher net margin — 13.2% vs 12.2%, a 1.0% gap on every dollar of revenue. On growth, National Storage Affiliates Trust posted the faster year-over-year revenue change (-1.6% vs -2.7%). National Storage Affiliates Trust produced more free cash flow last quarter ($299.8M vs $87.2M). Over the past eight quarters, HAEMONETICS CORP's revenue compounded faster (0.4% CAGR vs -2.4%).
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
National Storage Affiliates Trust is a U.S.-headquartered real estate investment trust focused on self-storage assets. It owns, operates and acquires self-storage facilities across dozens of U.S. states, offering secure storage solutions for residential and commercial customers.
HAE vs NSA — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $339.0M | $187.0M |
| Net Profit | $44.7M | $22.9M |
| Gross Margin | 59.7% | 72.5% |
| Operating Margin | 19.9% | 20.2% |
| Net Margin | 13.2% | 12.2% |
| Revenue YoY | -2.7% | -1.6% |
| Net Profit YoY | 19.3% | 36.8% |
| EPS (diluted) | $0.95 | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $339.0M | $187.0M | ||
| Q3 25 | $327.3M | $188.7M | ||
| Q2 25 | $321.4M | $188.8M | ||
| Q1 25 | $330.6M | $188.4M | ||
| Q4 24 | $348.5M | $190.1M | ||
| Q3 24 | $345.5M | $193.6M | ||
| Q2 24 | $336.2M | $190.4M | ||
| Q1 24 | — | $196.1M |
| Q4 25 | $44.7M | $22.9M | ||
| Q3 25 | $38.7M | $18.4M | ||
| Q2 25 | $34.0M | $19.5M | ||
| Q1 25 | $58.0M | $13.0M | ||
| Q4 24 | $37.5M | $16.7M | ||
| Q3 24 | $33.8M | $18.7M | ||
| Q2 24 | $38.4M | $17.1M | ||
| Q1 24 | — | $59.0M |
| Q4 25 | 59.7% | 72.5% | ||
| Q3 25 | 59.5% | 70.7% | ||
| Q2 25 | 59.8% | 70.5% | ||
| Q1 25 | 58.4% | 70.7% | ||
| Q4 24 | 55.5% | 72.5% | ||
| Q3 24 | 54.2% | 72.8% | ||
| Q2 24 | 52.0% | 72.6% | ||
| Q1 24 | — | 72.1% |
| Q4 25 | 19.9% | 20.2% | ||
| Q3 25 | 17.9% | 15.8% | ||
| Q2 25 | 16.8% | 16.5% | ||
| Q1 25 | 21.6% | 11.0% | ||
| Q4 24 | 16.9% | 14.5% | ||
| Q3 24 | 15.0% | 15.8% | ||
| Q2 24 | 11.8% | 17.2% | ||
| Q1 24 | — | 48.9% |
| Q4 25 | 13.2% | 12.2% | ||
| Q3 25 | 11.8% | 9.8% | ||
| Q2 25 | 10.6% | 10.3% | ||
| Q1 25 | 17.5% | 6.9% | ||
| Q4 24 | 10.8% | 8.8% | ||
| Q3 24 | 9.8% | 9.7% | ||
| Q2 24 | 11.4% | 9.0% | ||
| Q1 24 | — | 30.1% |
| Q4 25 | $0.95 | $0.23 | ||
| Q3 25 | $0.81 | $0.17 | ||
| Q2 25 | $0.70 | $0.19 | ||
| Q1 25 | $1.17 | $0.10 | ||
| Q4 24 | $0.74 | $0.19 | ||
| Q3 24 | $0.66 | $0.18 | ||
| Q2 24 | $0.74 | $0.16 | ||
| Q1 24 | — | $0.65 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $363.4M | $23.3M |
| Total DebtLower is stronger | $1.2B | — |
| Stockholders' EquityBook value | $911.5M | $946.0M |
| Total Assets | $2.5B | $5.1B |
| Debt / EquityLower = less leverage | 1.34× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $363.4M | $23.3M | ||
| Q3 25 | $296.4M | $26.3M | ||
| Q2 25 | $292.9M | $26.1M | ||
| Q1 25 | $306.8M | $19.3M | ||
| Q4 24 | $320.8M | $50.4M | ||
| Q3 24 | $299.3M | $69.9M | ||
| Q2 24 | $344.4M | $59.0M | ||
| Q1 24 | — | $64.2M |
| Q4 25 | $1.2B | — | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $1.2B | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $911.5M | $946.0M | ||
| Q3 25 | $849.2M | $973.1M | ||
| Q2 25 | $882.3M | $1.0B | ||
| Q1 25 | $820.8M | $1.0B | ||
| Q4 24 | $906.9M | $1.1B | ||
| Q3 24 | $878.9M | $986.9M | ||
| Q2 24 | $905.4M | $1.2B | ||
| Q1 24 | — | $1.3B |
| Q4 25 | $2.5B | $5.1B | ||
| Q3 25 | $2.4B | $5.1B | ||
| Q2 25 | $2.5B | $5.2B | ||
| Q1 25 | $2.5B | $5.3B | ||
| Q4 24 | $2.5B | $5.4B | ||
| Q3 24 | $2.5B | $5.4B | ||
| Q2 24 | $2.5B | $5.3B | ||
| Q1 24 | — | $5.4B |
| Q4 25 | 1.34× | — | ||
| Q3 25 | 1.44× | — | ||
| Q2 25 | 1.39× | — | ||
| Q1 25 | 1.49× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $93.6M | $338.5M |
| Free Cash FlowOCF − Capex | $87.2M | $299.8M |
| FCF MarginFCF / Revenue | 25.7% | 160.3% |
| Capex IntensityCapex / Revenue | 1.9% | 20.7% |
| Cash ConversionOCF / Net Profit | 2.09× | 14.79× |
| TTM Free Cash FlowTrailing 4 quarters | $308.1M | $541.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $93.6M | $338.5M | ||
| Q3 25 | $111.3M | $100.2M | ||
| Q2 25 | $17.4M | $79.9M | ||
| Q1 25 | $116.6M | $85.6M | ||
| Q4 24 | $43.8M | $363.1M | ||
| Q3 24 | $48.8M | $105.7M | ||
| Q2 24 | $-27.4M | $83.2M | ||
| Q1 24 | — | $94.0M |
| Q4 25 | $87.2M | $299.8M | ||
| Q3 25 | $106.3M | $88.0M | ||
| Q2 25 | $13.6M | $73.8M | ||
| Q1 25 | $100.9M | $79.9M | ||
| Q4 24 | $35.2M | $344.4M | ||
| Q3 24 | $39.4M | $101.8M | ||
| Q2 24 | $-33.1M | $79.5M | ||
| Q1 24 | — | $88.6M |
| Q4 25 | 25.7% | 160.3% | ||
| Q3 25 | 32.5% | 46.6% | ||
| Q2 25 | 4.2% | 39.1% | ||
| Q1 25 | 30.5% | 42.4% | ||
| Q4 24 | 10.1% | 181.2% | ||
| Q3 24 | 11.4% | 52.6% | ||
| Q2 24 | -9.8% | 41.7% | ||
| Q1 24 | — | 45.2% |
| Q4 25 | 1.9% | 20.7% | ||
| Q3 25 | 1.5% | 6.5% | ||
| Q2 25 | 1.2% | 3.2% | ||
| Q1 25 | 4.7% | 3.0% | ||
| Q4 24 | 2.5% | 9.8% | ||
| Q3 24 | 2.7% | 2.0% | ||
| Q2 24 | 1.7% | 1.9% | ||
| Q1 24 | — | 2.7% |
| Q4 25 | 2.09× | 14.79× | ||
| Q3 25 | 2.88× | 5.44× | ||
| Q2 25 | 0.51× | 4.10× | ||
| Q1 25 | 2.01× | 6.59× | ||
| Q4 24 | 1.17× | 21.70× | ||
| Q3 24 | 1.44× | 5.65× | ||
| Q2 24 | -0.71× | 4.88× | ||
| Q1 24 | — | 1.59× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HAE
| Hospital | $143.5M | 42% |
| Plasma Productsand Services | $138.9M | 41% |
| Blood Center Productsand Services | $56.6M | 17% |
NSA
Segment breakdown not available.
